​

Fennec Pharmaceuticals Ownership | Who Owns Fennec Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Fennec Pharmaceuticals Ownership Summary

Fennec Pharmaceuticals is owned by 12.66% institutional investors, 16.09% insiders, and 71.25% retail investors. Southpoint capital advisors lp is the largest institutional shareholder, holding 14.74% of FENC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.20% of its assets in Fennec Pharmaceuticals shares.

FENC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockFennec Pharmaceuticals12.66%16.09%71.25%
SectorHealthcare Stocks 42.54%10.82%46.64%
IndustryBiotech Stocks 45.21%10.75%44.04%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Southpoint capital advisors lp4.08M14.74%$38.16M
Sonic gp2.41M8.80%$15.21M
Solas capital management2.19M7.91%$20.48M
Rosalind advisors2.08M7.51%$19.44M
Blackrock1.19M4.39%$7.25M
Blackrock funding, inc. /de1.21M4.38%$11.34M
Vanguard group955.76K3.45%$8.95M
Aigh capital management681.50K2.46%$6.38M
State street341.20K1.23%$3.19M
Tang capital management334.59K1.21%$3.13M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sonic gp2.41M33.54%$15.21M
Solas capital management2.19M12.50%$20.48M
Harbert fund advisors177.81K10.86%$1.66M
Rosalind advisors2.08M6.64%$19.44M
Lion point capital, lp123.00K6.54%$1.15M
Aigh capital management681.50K1.80%$6.38M
Southpoint capital advisors lp4.08M1.00%$38.16M
Hartford financial management50.65K0.13%$474.05K
Tang capital management334.59K0.12%$3.13M
Gendell jeffrey l139.56K0.02%$1.31M

Top Buyers

HolderShares% AssetsChange
Tang capital management334.59K0.12%314.07K
Blackrock1.19M0.00%259.78K
Aigh capital management681.50K1.80%229.10K
Rosalind advisors2.08M6.64%31.20K
Jane street group72.63K0.00%22.64K

Top Sellers

HolderShares% AssetsChange
Essex investment management---144.22K
Harbert fund advisors177.81K10.86%-109.80K
Dg capital management---84.21K
Eam investors---78.66K
Lion point capital, lp123.00K6.54%-72.70K

New Positions

HolderShares% AssetsChangeValue
Xtx topco21.25K0.01%21.25K$198.87K
Quadrature capital15.32K0.00%15.32K$143.56K
Susquehanna group, llp12.43K-12.43K$78.57K
Acadian asset management10.71K0.00%10.71K$100.00K
Renaissance10.60K0.00%10.60K$99.22K

Sold Out

HolderChange
Newedge advisors-1.00
Nelson, van denburg & campbell wealth management group-3.00
Capital performance advisors llp-5.00
Ifp advisors-7.00
Toronto dominion bank-25.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202537-48.61%3,501,549-73.61%120.55%10-73.68%12-45.45%
Jun 30, 20257713.24%13,599,9831.57%492.09%4033.33%2420.00%
Mar 31, 20255-92.19%4,328,394-73.03%150.46%2-94.87%1-92.31%
Dec 31, 202431-50.00%4,180,599-72.00%150.51%23-30.30%4-73.33%
Sep 30, 202462-14,931,2843.97%541.93%33-19.51%1536.36%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF882.05K3.20%5.84K
Vanguard Total Stock Mkt Idx Inv776.33K2.81%-17.09K
iShares Russell 2000 ETF539.23K1.94%-
Fidelity Small Cap Index234.34K0.84%-6.71K
iShares Russell 2000 Value ETF149.01K0.54%-
State St Russell Sm/Mid Cp® Indx NL Cl C122.70K0.44%-
State St Russell Sm/Mid Cp® Indx SL Cl I122.70K0.44%-
Vanguard Russell 2000 ETF111.76K0.40%-7.55K
State St Russell Sm Cap® Indx SL Cl I69.00K0.25%-
Schwab Small Cap Index61.29K0.22%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 05, 2025Raykov Rosty-Sell$75.40K
Nov 18, 2025Southpoint Capital Advisors LP-Sell$170.05K
Nov 17, 2025Southpoint Capital Advisors LP-Sell$755.19K
Nov 14, 2025Southpoint Capital Advisors LP-Sell$1.28M
Nov 05, 2025Raykov Rosty-Sell$81.00K

Insider Transactions Trends

DateBuySell
2025 Q4-10
2025 Q3-4
2024 Q4-1
2024 Q3-4
2024 Q2218

FENC Ownership FAQ

Who Owns Fennec Pharmaceuticals?

Fennec Pharmaceuticals shareholders are primarily institutional investors at 12.66%, followed by 16.09% insiders and 71.25% retail investors. The average institutional ownership in Fennec Pharmaceuticals's industry, Biotech Stocks , is 45.21%, which Fennec Pharmaceuticals falls below.

Who owns the most shares of Fennec Pharmaceuticals?

Fennec Pharmaceuticals’s largest shareholders are Southpoint capital advisors lp (4.08M shares, 14.74%), Sonic gp (2.41M shares, 8.80%), and Solas capital management (2.19M shares, 7.91%). Together, they hold 31.44% of Fennec Pharmaceuticals’s total shares outstanding.

Does Blackrock own Fennec Pharmaceuticals?

Yes, BlackRock owns 4.39% of Fennec Pharmaceuticals, totaling 1.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 7.25M$. In the last quarter, BlackRock increased its holdings by 259.78K shares, a 28.01% change.

Who is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sonic gp is Fennec Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 33.54% of its assets in 2.41M Fennec Pharmaceuticals shares, valued at 15.21M$.

Who is the top mutual fund holder of Fennec Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Fennec Pharmaceuticals shares, with 3.20% of its total shares outstanding invested in 882.05K Fennec Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools